HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 1071822Generated: November 2, 2026
m-Chloroperbenzoic acid → HCID 69732331, compound
https://huagongshe.com/reaction/1071822
Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | m-Chloroperbenzoic acid | HCID 70297 | — |
| Reactant | HCID 69730436 | HCID 69730436 | — |
| Reactant | HCID 131724998 | HCID 131724998 | — |
| Reactant | HCID 131724999 | HCID 131724999 | — |
| Product | HCID 69732331 | HCID 69732331 | — |
Reaction Steps
Finally, T. Aoki et al. (Tetrahedron 1983, 34/15, 2515-2556—in particular pages 2520-2525) disclose the synthesis of diphenylmethyl 7β-(2-thienylacetamino)-3-(1-methyl-1H-tetrazol-5-yl)thiometyl-3-cephem-4-carboxylate, which involves the preparation of diphenylmethyl 7β-(2-thienylacetamino)-3-(l-methyl-1H-tetrazol-5-yl)-3-methylthiocepham-4-carboxylate via the corresponding 3-methylthio-3-chloromethylcepham analog and the reaction of said diphenylmethyl 7β-(2-thienylacetamino)-3-(1-methyl-1H-tetrazol-5-yl)-3-methylthiocepham-4-carboxylate with m-chloroperbenzoic acid in order to remove methylmercaptan and form a 3-(1-methyl-1H-tetrazol-5-yl)-3-cephem structure via the corresponding 1-oxide. However, the method described by Aoki et al. is not transposable to the preparation of third-generation-cefalosporins because the reactants employed affect the amino group which is present on the thiazole ring and is sensitive thereto.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US06906187B2 |
|---|
| Source dataset | uspto-grants-2005_06 |
|---|
| ORD ID | ord-b4955aac6eb84df9ab933ddc1fcba28f |
|---|
| Source note | uspto-grants-2005_06 |
|---|